The IL-8 production by Streptococcal pyrogenic exotoxin B. 2009

Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
Institute of Basic Medical Sciences, Department of Biochemistry, National Cheng Kung University Medical College, Tainan 70101, Taiwan.

We have previously identified alpha(v)beta(3) and Fas as receptors for the streptococcal pyrogenic exotoxin B (SPE B), and G308S, a mutant of SPE B with RSD motif, which interacts with Fas only. This study aims to evaluate how SPE B interacts with cells to induce the production of IL-8. Our results showed that following exposure to SPE B or G308S, the levels of IL-8 protein and mRNA were increased and the increase was inhibited by the addition of anti-Fas antibody, suggesting that the increased production of IL-8 by SPE B is mediated through Fas receptor. In the presence of G308S, the association of FADD and procaspase 8, and activation of NF-kappaB were also detected. The application of siRNA of FADD and of procaspase 8 could inhibit the NF-kappaB activity. The proteolytic activity of caspase 8 was required for the NF-kappaB activity. Further studies showed that G308S could increase the phosphorylation of ERK and the translocation of NF-kappaB into the nucleus, and the inhibition of ERK phosphorylation decreased the IL-8 production, mRNA expression and activation of NF-kappaB. In addition, siRNA of procaspase 8 could inhibit the G308S-induced cleavage of MEKK1, binding of MEKK1 to caspase 8, activation of ERK and the NF-kappaB activity. Taken together, the production of IL-8 by SPE B in A549 cells is mediated by Fas, and followed by the activation of FADD, caspase 8, MEKK1, ERK and NF-kappaB.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005098 Exotoxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Exotoxin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
November 1994, Canadian journal of microbiology,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
February 2005, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
May 1978, Infection and immunity,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
February 2022, Nature,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
January 2018, RNA biology,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
May 1986, Journal of bacteriology,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
April 2016, Microbial pathogenesis,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
October 2010, Laboratory investigation; a journal of technical methods and pathology,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
January 2000, Methods in molecular medicine,
Chia-Wen Chang, and Siang-Yu Wu, and Woei-Jer Chuang, and Yee-Shin Lin, and Jiunn-Jong Wu, and Ching-Chuan Liu, and Pei-Jane Tsai, and Ming-T Lin
September 2001, The Journal of infectious diseases,
Copied contents to your clipboard!